Figure 1. Baseline characteristics of newly diagnosed endometrial cancers.

A, cfDNA concentrations in ng/ml plasma at baseline in newly diagnosed endometrial cancers according to surgical stage. Wilcoxon rank sum test. B, cfDNA concentrations in ng/ml plasma at baseline in newly diagnosed endometrial cancers according to histologic type. HG Carc, high-grade carcinoma; Dediff, dedifferentiated; Carcinosarc, carcinosarcoma. Wilcoxon rank sum test was used for comparisons. C, somatic mutations identified in primary newly diagnosed endometrial cancers included in this study. Mutation types are color coded according to the legend. Information on the histologic subtype, tumor grade of endometrioid endometrial cancers, and molecular subtype are provided on top.